| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |